Activists push for magic mushroom decriminalization in DC

psychedelics dc x
Credit: Cannabis Investor
[July 8,] activists presented more than 36,000 signatures to the [Washington DC] Board of Elections. If the signatures hold up through the verification process, voters in the nation’s capital will face a November ballot initiative that would decriminalize psilocybin “magic” mushrooms and other natural psychedelics like mescaline.

If passed, it would be the first of its kind for an Eastern city; Denver became the first U.S. city to pass such an initiative in May 2019, with the California cities of Oakland and Santa Cruz following suit. It would also likely face efforts in Congress to overturn or block its implementation.

Activists are deemphasizing the recreational aspects of the drugs, focusing on the therapeutic and medical benefits as treatment for depression, trauma and addiction.

“D.C. could really lead the way on this,” said campaign manager Melissa Lavasani. “You shouldn’t bear the repercussions of the drug war while you are healing yourself.”

…

The proposed D.C. ballot initiative would apply to psilocybin mushrooms, iboga, mescaline and ayuhuasca but not to peyote or to human-made psychedelics like LSD. It would instruct the Metropolitan Police Department to treat such substances as a low priority. If successful, Lavasani said she envisions patients being able to consume such substances in controlled circumstances and in consultation with doctors or therapists.

Read the original post

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Professional Portrait Earth Backdrop
Viewpoint: November 13 is the long-predicted global doomsday. How a respected scientist got population growth catastrophe predictions so spectacularly wrong—fueling decades of junk science
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ADA Lanyard on Woodgrain Desk
How the Trumpification of medicine is roiling — and maybe destroying—the American Diabetes Association
Tropical Yacht Conversation
Kennedy faces Congressional ethics investigation for accepting massive gifts from anti-vaccine and ketamine wellness grifter
Screenshot-2026-11-09-at-1.40.16-PM
As measles cases continue to surge, RFK Jr. blocks CDC scientists from issuing emergency alert warning unvaccinated pregnant women of significantly increased risks
Colorful GLP-1 Pens with Clocks_tagger
Biohacker influencers are claiming GLP-1 weight loss drugs extend lifespan. One mice experiment suggests there may be some truth to the claim
Vegan and Unvaxxed Salad Protest
Viewpoint: ‘Sanitation and nutrition not vaccines’: The rejectionists' latest false substitute for staying up to date on your shots
Paper Field Portraits with Distant Barn (1)
Viewpoint: After MAHA-Republican election debacle, controversial campaigner Zen Honeycutt looks to sympathetic Democrats to promote her anti-chemical agenda
Neon Binary Code Bacteriophage
AI medicine breakthrough: Could ‘good viruses’ created by AI cure deadly diseases and infections?
gmos africa
Slow adoption: Only 15 of Africa’s 54 nations embrace genetic engineering food revolution. Here’s why
Testosterone-and-NATO-Editorial-Collage
Unintended consequences: Hegseth’s proposed controversial ‘low testosterone’ screen could flag 150,000 Army men. What happens next?  
Screenshot-2026-11-09-at-3.01.19-PM
Are Texas data centers killing calves? Debunking viral AI claims
Data Center Power and Cost Surge
It’s the ‘juice’: What the AI data center wars are really all about
Microscopic IVF Egg Injection
With technical barriers to human embryo editing falling, ethical concerns escalate
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.